StonvexLoading…
StonvexStonvexStonvexCore line items from PHM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.31B | $17.95B | $16.06B | $16.00B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $2.22B | $3.08B | $2.60B | $2.62B |
EPS (Diluted) | $11.12 | $14.69 | $11.72 | $11.01 |
Total Assets | $18.05B | $17.36B | $16.09B | $14.80B |
Total Liabilities | $5.06B | $5.24B | $5.70B | $5.88B |
Cash & Equivalents | $1.98B | $1.61B | $1.81B | $1.05B |
Free Cash Flow OCF − CapEx | $1.75B | $1.56B | $2.10B | $555.80M |
Shares Outstanding | 192.72M | 202.91M | 212.56M | 225.84M |